멸균 자동 비활성화 백신용 주사기 시장 보고서 : 동향, 예측, 경쟁 분석(-2031년)
Sterile Self-Disable Vaccine Syringe Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드 : 1805986
리서치사 : Lucintel
발행일 : 2025년 09월
페이지 정보 : 영문 150 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,850 ₩ 5,568,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,650 ₩ 6,725,000
PDF (2 Users License) help
PDF 보고서를 동일 사업장에서 2명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,350 ₩ 7,737,000
PDF (5 Users License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,050 ₩ 10,196,000
PDF (Corporate License) help
PDF 보고서를 기업 내 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계 멸균 자동 비활성화 백신용 주사기 시장의 미래는 병원과 진료소 시장에서의 기회로 유망시되고 있습니다. 세계의 멸균 자동 비활성화 백신용 주사기 시장은 2024-2031년에 CAGR 9.8%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 백신 생산 및 유통 증가, 주사바늘 안전에 대한 관심 증가, 정부 및 보건 의료에 대한 노력입니다.

멸균 자동 비활성화 백신용 주사기 시장의 새로운 동향

백신 접종 프로그램의 안전성, 효율성, 접근성 향상에 초점을 맞춘 새로운 동향에 힘입어 전 세계에서 멸균 자동 비활성화 백신용 주사기 시장이 빠르게 변화하고 있습니다.

이러한 추세는 보다 진보적이고 안전하며 접근이 용이한 백신 투여 방식으로의 전환을 보여줍니다. 전 세계 의료 시스템이 백신 접종률 향상과 주사바늘 사용의 안전성 확보에 초점을 맞추고 있는 가운데, 멸균 주사기는 감염 예방과 백신 접종 과정 개선에 있으며, 점점 더 중요한 역할을 하고 있습니다.

멸균 자동 비활성화 백신용 주사기 시장의 최근 동향

멸균 자동 비활성화 백신용 주사기 시장에서는 최근 전 세계에서 백신 전달 시스템의 안전성, 효율성, 경제성을 향상시키기 위한 혁신과 도입이 활발히 이루어지고 있습니다. 사용 후 자동으로 주사바늘을 수납할 수 있도록 설계된 이 주사기는 특히 COVID-19의 세계적 대유행으로 인해 백신 접종 프로그램의 중요한 구성 요소로 각광받고 있습니다. 이 주사기는 바늘에 찔리는 손상을 방지하고 교차 오염의 위험을 줄이며 의료진과 환자 모두의 전반적인 안전성을 향상시키는 중요한 솔루션을 제공합니다. 최근 새로운 제조 기술의 도입, 규제 당국의 지원 강화, 안전한 의료기기에 대한 수요 증가로 인해 시장 성장에 박차를 가하고 있습니다. 이러한 혁신은 선진국과 신흥 시장에서 대규모 백신 접종 캠페인을 중심으로 예방접종 활동의 개선에 점점 더 중점을 두고 있는 상황에 대응하기 위한 것입니다.

이러한 개발은 멸균 자동 비활성화 백신용 주사기 시장의 급속한 성장에 기여하고 있습니다. 백신 접종 시스템의 안전성과 효율성을 우선시하는 국가가 늘어남에 따라 이러한 첨단 주사기에 대한 수요는 전 세계에서 계속 증가하여 혁신을 촉진하고 전 세계 백신 접근성을 개선할 것으로 예측됩니다.

목차

제1장 개요

제2장 시장 개요

제3장 시장 동향과 예측 분석

제4장 유형별, 세계의 멸균 자동 비활성화 백신용 주사기 시장

제5장 용도별, 세계의 멸균 자동 비활성화 백신용 주사기 시장

제6장 지역 분석

제7장 북미의 멸균 자동 비활성화 백신용 주사기 시장

제8장 유럽의 멸균 자동 비활성화 백신용 주사기 시장

제9장 아시아태평양의 멸균 자동 비활성화 백신용 주사기 시장

제10장 기타 지역의 멸균 자동 비활성화 백신용 주사기 시장

제11장 경쟁 분석

제12장 기회와 전략 분석

제13장 밸류체인에서 주요 기업의 기업 개요

제14장 부록

KSA
영문 목차

영문목차

The future of the global sterile self-disable vaccine syringe market looks promising with opportunities in the hospital and clinic markets. The global sterile self-disable vaccine syringe market is expected to grow with a CAGR of 9.8% from 2024 to 2031. The major drivers for this market are the increasing vaccine production and distribution, the rising focus on needle safety, and government and healthcare initiatives.

Emerging Trends in the Sterile Self-Disable Vaccine Syringe Market

The sterile self-disable vaccine syringe market is undergoing rapid transformation driven by emerging trends that focus on improving safety, efficiency, and accessibility in vaccination programs globally.

These trends indicate a shift towards more advanced, safer, and accessible vaccine administration methods. As global healthcare systems focus on improving vaccination rates and ensuring safety in needle usage, self-disable syringes are playing an increasingly vital role in preventing infections and improving vaccination processes.

Recent Developments in the Sterile Self-Disable Vaccine Syringe Market

The sterile self-disable vaccine syringe market has seen recent innovations and introductions aimed at enhancing safety, efficiency, and affordability in vaccine delivery systems worldwide. These syringes, designed to automatically retract the needle after use, are gaining traction as key components in vaccination programs, especially in the wake of the global COVID-19 pandemic. They offer a critical solution to preventing needlestick injuries, reducing the risk of cross-contamination, and improving overall safety for both healthcare workers and patients. The recent introduction of new manufacturing technologies, increased regulatory support, and growing demand for safer medical devices are driving growth in the market. These innovations aim to address the increasing focus on improving immunization efforts, particularly in mass vaccination campaigns across developed and emerging markets.

These developments are contributing to the rapid growth of the sterile self-disable vaccine syringe market. As more nations prioritize the safety and efficiency of vaccination systems, the demand for these advanced syringes is expected to continue rising globally, driving innovations and improving access to vaccines worldwide.

Strategic Growth Opportunities in the Sterile Self-Disable Vaccine Syringe Market

The sterile self-disable vaccine syringe market is poised for significant growth as the global demand for safe and efficient vaccination systems increases. With heightened awareness around the importance of vaccination and the need for safety protocols in healthcare, these syringes offer a strategic solution to ensure the safety of both patients and healthcare workers. They automatically retract the needle after use, minimizing the risk of needle-stick injuries and potential disease transmission. The increasing emphasis on mass immunization campaigns, coupled with technological advancements in syringe design, regulatory support, and a growing preference for disposable and tamper-proof vaccine delivery systems, positions the sterile self-disable syringe as a critical component in modern healthcare strategies. As countries continue to expand immunization programs, these syringes will be integral to achieving broader public health goals while enhancing operational efficiency.

These strategic opportunities highlight the potential for continued growth in the sterile self-disable vaccine syringe market. By focusing on technological advancements, expanding into emerging markets, and capitalizing on regulatory trends, manufacturers can position themselves for success in a rapidly evolving industry.

Sterile Self-Disable Vaccine Syringe Market Driver and Challenges

The major drivers of the sterile self-disable vaccine syringe market include technological advancements, regulatory support, and a heightened focus on safety in vaccination programs. Challenges like high production costs, technological integration issues, and compliance with varying global regulations also shape the market landscape. These factors contribute to both opportunities and hurdles for manufacturers and healthcare providers in the growing market.

The factors responsible for driving the Sterile Self-Disable Vaccine Syringe market include:

1. Technological Innovation in Vaccine Administration: Advancements in syringe technology, including automatic needle retraction and enhanced sterility features, are key drivers. These innovations ensure safer vaccination practices by eliminating risks associated with needle reuse, thereby boosting the adoption of self-disable syringes in vaccination programs globally.

2. Government Regulations and Health Safety Standards: Governments worldwide are increasingly mandating the use of safer vaccine syringes to prevent needlestick injuries. Compliance with these regulations is driving the market, especially in public health campaigns, where the risk of infection is high.

3. Global Focus on Preventing Needlestick Injuries: The global awareness of needlestick injuries and the associated risks, including bloodborne diseases, is promoting the adoption of self-disable syringes. These syringes prevent accidental needle sticks by automatically disabling the needle after use, making them a safer option for both healthcare workers and patients.

4. Growing Immunization Efforts Worldwide: As vaccination campaigns grow in scale, particularly in emerging markets, there is a rising need for syringes that are not only cost-effective but also safe and efficient. Self-disable syringes meet these requirements, driving increased adoption.

5. Economic Growth in Emerging Markets: Emerging markets are increasingly focusing on improving healthcare access, and the expansion of immunization programs is driving the demand for sterile self-disable syringes. As these regions continue to invest in healthcare infrastructure, there is a substantial opportunity for growth.

Challenges in the Sterile Self-Disable Vaccine Syringe market are:

1. High Production Costs: The development and production of self-disable syringes with advanced safety features involve significant costs, which may limit their affordability for healthcare systems in low-income countries. High production costs can hinder broader market adoption.

2. Technological Integration: Integrating advanced syringe technologies with existing healthcare infrastructure can be challenging. Older vaccination systems may not be compatible with new self-disable syringes, requiring expensive upgrades and increased complexity.

3. Regulatory Compliance Variability: Regulatory frameworks governing medical devices vary significantly across regions, which can delay market entry and add costs for manufacturers. Adhering to the diverse regulatory standards is a significant challenge in global market expansion.

The sterile self-disable vaccine syringe market is driven by technological innovations, regulatory mandates, and increased focus on safety. However, challenges such as high production costs, integration complexities, and regulatory compliance issues could slow adoption. Addressing these challenges will be crucial to ensuring the continued growth and success of this market in the coming years.

List of Sterile Self-Disable Vaccine Syringe Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leveraging integration opportunities across the value chain. With these strategies, sterile self-disable vaccine syringe companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the sterile self-disable vaccine syringe companies profiled in this report include:

Sterile Self-Disable Vaccine Syringe Market by Segment

The study includes a forecast for the global sterile self-disable vaccine syringe market by type, application, and region.

Sterile Self-Disable Vaccine Syringe Market by Type [Value from 2019 to 2031]:

Sterile Self-Disable Vaccine Syringe Market by Application [Value from 2019 to 2031]:

Sterile Self-Disable Vaccine Syringe Market by Region [Value from 2019 to 2031]:

Country Wise Outlook for the Sterile Self-Disable Vaccine Syringe Market

The sterile self-disable vaccine syringe market has witnessed significant advancements across several regions, driven by the increasing demand for safer vaccination processes, heightened health and safety regulations, and the global focus on preventing the reuse of needles. These self-disable syringes are designed to automatically retract the needle after injection, minimizing the risk of needlestick injuries and potential cross-contamination. The market for these syringes is growing rapidly in key regions like the United States, China, Germany, India, and Japan, as governments and healthcare organizations adopt more stringent safety measures and focus on improving vaccination programs.

Features of the Global Sterile Self-Disable Vaccine Syringe Market

Analysis of the competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

Table of Contents

1. Executive Summary

2. Market Overview

3. Market Trends & Forecast Analysis

4. Global Sterile Self-Disable Vaccine Syringe Market by Type

5. Global Sterile Self-Disable Vaccine Syringe Market by Application

6. Regional Analysis

7. North American Sterile Self-Disable Vaccine Syringe Market

8. European Sterile Self-Disable Vaccine Syringe Market

9. APAC Sterile Self-Disable Vaccine Syringe Market

10. ROW Sterile Self-Disable Vaccine Syringe Market

11. Competitor Analysis

12. Opportunities & Strategic Analysis

13. Company Profiles of the Leading Players Across the Value Chain

14. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기